研究開発の結果、肝がん治療におけるSBRTの5年局所制御率は82%と高く、生存率も大幅に向上していることが示されています。肝がんに加えて、SBRTは肺がんの治療にも使用されています。肝がん病変の位置が適切で、患者の肝機能が許容できる場合は、手術が依然として最も理想的な治療法です。しかし、手術が不可能な場合は、できるだけ早く放射線腫瘍科に相談し、SBRTの適応を評価し、治療計画を開始してください
R&D have shown that the five-year local control rate of SBRT in the treatment of liver cancer is as high as 82%, and the survival rate has also been significantly improved. In addition to liver cancer, SBRT has also been used to treat lung cancer. It is reminded that if the location of the liver cancer lesion is appropriate and the patient s liver function allows, surgery is still the most ideal treatment method. However, for those who cannot undergo surgery, they should consult the Department of Radiation Oncology as soon as possible to evaluate whether SBRT is appropriate and start treatment planning as soon as possible. [*)]
住戶編號:2993626
檢舉原因
心情: 
